Exibindo 541 - 570 de 2730
In reference to International Women’s Day, the Pasteur Institute, in Paris, paid homage to five female scientists that are part of the institution's international scientific cooperation network. Among them, representing the Americas, was researcher Teca Galvão, from the Laboratory for Functional Genomics and Bioinformatics of the Oswaldo Cruz Institute (IOC/Fiocruz).
The homage highlighted the specialist’s education, which includes several foreign institutions, and her commitment to research how the resistance to antibiotics is determined by genetic diversity in bacteria isolated from…
Article
An article published in Nature Biomedical Engineering, last Monday (March 7th), reveals the potential use of synthetic biosensors in rapid, decentralized, and low-cost tests for the diagnosis of patients infects with the zika virus. The study was led by scientists of the University of Toronto (CA), who developed the sensors and the portable digital platform where samples are processed, and had the partnership of researchers from Fiocruz Pernambuco to evaluate this technique, using samples of patients from Recife (in the state of Pernambuco). It is one of the first field trials applying…
Article
March is celebrated as the month of International Women’s Day, but it is also the time to debate gender inequalities and guarantee of rights. This issue was highlighted by the ambassador of UN Women for Latin America, María del Carmen Squeff, at the Advanced Seminar in Global Health and Health Diplomacy of the Fiocruz Global Health Center (CRIS/Fiocruz), last Wednesday (March 9th). At the event, which was attended by researchers in the field, she highlighted the agency’s priorities for 2022 and emphasized the importance of alliances with institutions such as Fiocruz.
“The origin of…
Article
During a conference in London, attended by the world’s most prominent health authorities and specialists, Fiocruz president, Nísia Trindade Lima, emphasized the need to decentralize vaccine production and to strengthen investments in research and development, in order to reduce inequalities between countries. Her statement was made during the Global Summit for Preparation for Pandemics, last Tuesday (March 8th). Organized by the Coalition for Epidemics Preparedness Innovations (Cepi) and by the United Kingdom, the event was looking for support for the #100DaysMission campaign, so that in…
Article
A Fundação Oswaldo Cruz, por meio do Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos/Fiocruz), disponibiliza para o Ministério da Saúde (MS) as primeiras doses da vacina Covid-19 (recombinante) produzidas com o Ingrediente Farmacêutico Ativo (IFA) nacional. O primeiro lote de vacinas nacionais foi liberado pelo controle de qualidade interno de Bio-Manguinhos/Fiocruz no dia 14 de fevereiro.
As pouco mais de 550 mil doses disponibilizadas já compõem as entregas da Fiocruz contratadas pelo Ministério da Saúde para 2022 (foto: Bio-Manguinhos/Fiocruz)
“A liberação das primeiras…
Article
We all had some degree of hope that the end of 2021 and the beginning of 2022 would bring us the much-awaited retraction of the pandemic. However, the emergence of the new Omicron variant dragged us away from the end of the tunnel we were longing for. Many countries, including some with powerful health systems, excellent living conditions, and high levels of vaccination, are hitting record numbers of contagions every day.
So far, the challenge on the horizon for 2022 is to overcome the pandemic and the immense sanitary and socio-economic inequality, achieve social and economic recovery…
Article
Science, technology and innovation to create resiliency, recover the planet from the impacts of COVID-19 and prepare it to face future health crises, including the ones resulting from environmental problems. This was the focus of the Global Sustainable Technology and Inovation Conference (G-Stic), an international reference in the debate that relates science, technology and innovation to the 2030 Agenda, which took place in Dubai from January 17th to 19th, 2022. Fiocruz takes part in it since 2019, through Fiocruz Strategy for the 2030 Agenda (EFA 2030), being invited by G-Stic to be a cohost…
Article
At a moment in which the world is watching a new peak of COVID-19 cases, preliminary analysis of a study on safetey and immunogenicity indicate that the use of the AstraZeneca vaccine as a booster shot increases the immune response against the variants of concern Beta, Delta, Alpha, and Gamma. An analysis made separately with samples of the research also shows an increased response of antibodies against the Omicron variant, which is behind the new wave of the disease.
Preliminary analysis of a study indicate that the use of the AstraZeneca vaccine as a booster shot increases the immune…
Article
Com o objetivo de ampliar a divulgação de notícias sobre Covid-19 para pessoas com deficiências auditivas, a Coordenação de Comunicação Social (CCS/Fiocruz) lançou um programa semanal que reúne as principais notícias publicadas na Agência Fiocruz de Notícias (AFN) traduzidas para a Língua Brasileira de Sinais (Libras) e com áudio em português.
Confira outras edições do AFN Acessibilidade.
Article
This Friday (January 7), Fiocruz received assent from the National Agency of Sanitary Surveillance (Anvisa) for the alteration in the register of the COVID-19 vaccine (recombinant), which requested the addition of the Foundation as a producer of the Active Pharmaceutical Ingredient (API). After the transference of the AstraZeneca technology and with the approval of Anvisa, the Foundation is now the first institution in the country that is allowed to produce and distribute a 100% Brazilian COVID-19 vaccine to the Ministry of Health.
Up to this moment, Fiocruz has the equivalent of 21…
Article
A study published on medRXiv, this Wednesday (December 29th), shows that the four vaccines applied in Brazil provide a high degree of additional protection against symptomatic infections and severe cases of COVID-19 in people who had already contracted Sars-CoV-2 previously. The study, led by Julio Croda and Manoel Barral-Neto, Fiocruz researchers, also reinforces the importance of a full vaccination scheme, even for those people.
Vaccine production at Bio-Manguinhos (Image: Bernardo Portella/Bio-Manguinhos/Fiocruz)
As preprint (without peer review), Effectiveness of CoronaVac, ChAdOx1,…
Article
A third AstraZeneca vaccine dose significantly increases neutralizing antibodies levels against the Ômicron variant (B.1.1.529), a new study indicates. The research was conducted independently by researchers from different institutions, including Fiocruz and Oxford University. And these results were published in preprint form on the bioRxiv platform (Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses) on Thursday.
A third AstraZeneca vaccine dose significantly increases neutralizing antibodies levels against the Ômicron variant (Image:Peter Ilicciev)
"As we have…
Article
For three consecutive mornings in Brazil, or three nights on the other side of the world, in China, the CAS-Fiocruz webinar on Infectous Diseases brought together researchers from the Foundation and the Chinese Academy of Sciences to exchange information on topics such as COVID-19, vaccines, zika, dengue, and other diseases common to both sides of the globe. The webinar took place on December 14th, 15th, and 16th.
The event opening, on Wednesday (12/14), was held by the president of Fiocruz, Nísia Trindade Lima, and the vice-president of CAS, Zhang Yaping. Nísia and Zhang highlighted the…
Article
As with other COVID-19 immunizers, a booster dose of AstraZeneca vaccine is also required after the complete vaccination schedule. This is indicated by a new study involving Brazil and Scotland, and published in the scientific journal The Lancet on Monday (12/20). The research, of which Fiocruz is part, shows the decrease in vaccine protection over time and in face of the new variants’ emergence.
The assessment, carried out at a time of intense variants of concern circulation and the Omicron emergence, reinforces the importance of the pandemic dynamics surveillance. The follow-up, which is…
Article
The ties between Fiocruz and the United States Consulate in Rio de Janeiro should become closer next year. On 12/16, the consul Jacqueline Ward and the president of Fiocruz, Nísia Trindade Lima, met at the Official Residence. On the agenda, scientific cooperation between Brazilian and American institutions, the XVI National Malaria Research Meeting and a parallel symposium organized by the Foundation and the National Institute of Allergy and Infectious Diseases/National Institutes of Health of the United States (NIAID-NIH), with the international experts' participation, such as Anthony Fauci…
Article
Continuing an institutional movement to promote science through the dissemination of actions, research, events and courses in other languages, Fiocruz has just incorporated two new courses to the Global Health Training Centre. This time they were "What is Open Science?" and "Open Access", which were translated from Portuguese into English and Spanish. They integrate the series on Open Science developed by the Fiocruz Virtual Campus in partnership with several actors of the Foundation. Both courses, of 10h each, are especially aimed at postgraduate students and researchers, but can be taken by…
Article
When the World Health Organization (WHO) decided to classify the Omicron strain of the new coronavirus as a variant of concern, it took into account the recommendations of a group of specialists. The so-called Technical Advisory Group on Sars-CoV-2 Evolution (TAG-VE) is a select group of scientists that includes a Brazilian virologist in its line-up: Brazilian researcher Marilda Siqueira, chief of the Laboratory of Measles and Respiratory Viruses of the Oswaldo Cruz Institute (IOC/Fiocruz).
The advisory group consists of 25 scientists of excellence in different specialties, such as virology,…
Article
A project resulting from a partnership between the Ministry of Health, Fiocruz, Lacen-PR, and the Federal University of São Paulo (Unifesp) was one of those selected by the U.S. Centers for Disease Control and Prevention (CDC) for funding, as part of the creation of two global networks aimed at fighting antimicrobial resistance. With Ana Paula Assef, head of the Hospital Infection Research Laboratory (LAPIH) at the Oswaldo Cruz Institute (IOC/Fiocruz), as the principal investigator, the Strengthening Brazilian Surveillance System for Antimicrobial Resistance program aims to reinforce the…
Article
The first edition of the bulletin on the COVID-19 vaccines' effectiveness in the Brazilian population, from Fiocruz's Vigivac project, was published on Thursday (12/9). The report, which presents analyses of the four vaccines administered in Brazil from January to October 2021, points out that all of them confer a great reduction in the risk of infection, hospitalizations, and death from COVID-19. Considering serious outcomes (hospitalization or death) in individuals aged 20-80 years, protection ranged from 83% to 99% for all immunizers. In the population under 60, all vaccines showed…
Article
In a pioneering initiative, the Foundation inaugurates this Monday (13/12), COVID-19 Biobank (BC19-Fiocruz). Located in Rio de Janeiro, at Expansão campus, BC19-Fiocruz will enable the design and conduct of research, technological development and clinical trials related to COVID-19, regardless of the geographic location of human biological material and viruses. With the capacity to store up to one and a half million samples of human and non-human biological materials, the Foundation's new unit will make a decisive contribution to Brazilian science.
Marcelo Queiroga, minister of Health, and…
Article
A research published today by The Lancet - one of the most prestigious scientific journals focused on the medical field in the world - brought together experts to explain how the economic downturn will affect for years and will be worse in developing countries. Without a consensus for preventive action, families and communities will be disproportionately affected. In the long run, inequalities in health, physical and socioeconomic well-being will widen worldwide. Fiocruz president, Nísia Trindade Lima, is one of the authors.
Image: Nailana Thiely/ Ascom Uepa
These…
Article
Designated by the United Nations, December 12th is celebrated every year as International Universal Health Coverage Day. The theme this year is Leave no one’s health behind: Invest in Health Systems for All - an issue that gained even more significance as the COVID-19 pandemic rolled on. This year’s campaign will feature a video showing people from all over the world who have shown leadership and vision in this matter, the so-called “Champions”. Among those invited to record a message is Fiocruz president, Nísia Trindade Lima, “for her personal leadership and for the work of the Foundation on…
Article
Fifteen years after visiting Fiocruz as a tourist, Pietro Lazzeri returned to the Foundation on Tuesday (12/07), this time as Switzerland ambassador. In office for six months, he met with Fiocruz members at the Fiocruz Global Health Center (CRIS/Fiocruz), where he proposed to expand technical and scientific cooperation. He also visited Bio-Manguinhos, where he found out that some of the machines used in the production of the COVID-19 vaccine came from his country.
Ambassador Pietro Lazzeri (at left) and Fiocruz met Fiocruz members at Fiocruz Golbal Health Center (Photo: Peter Ilicciev)…
Article
For one week Fiocruz will be at Expo Dubai. Starting on December 28th, visitors will be able to learn a little more about the Foundation's work and even take a virtual tour of Campus Manguinhos at the Brazil Pavilion. The World Expo takes place every five years and brings themes such as technology and sustainability. It began on October 1st, surrounded by care so that visitors can have interactive participation, but without crowds.
The Fiocruz exhibition project proposes to discuss health technology, access to health as a universal right, and health in the 2030 Agenda by approaching the…
Article
O Complexo Industrial de Biotecnologia em Saúde (Cibs) do Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos/Fiocruz) teve homologado (30/12) o vencedor da licitação para a sua construção, no campus de Santa Cruz, na Zona Oeste do Rio de Janeiro. O resultado foi publicado no Diário Oficial da União (DOU) e a empresa vencedora foi o Consórcio do Empreendimento NCPFI RJ. Com o processo concluído, o próximo passo será a assinatura do contrato para início das obras do futuro empreendimento, que será o maior centro de produção de produtos biológicos da América Latina e um dos…
Article
The Oswaldo Cruz Foundation, by means of the Fio-Schisto, the Translational Research Program in Schistosomiasis, informs that researcher Otávio Pieri, of the Oswaldo Cruz Institute (IOC), was invited to become part of the World Health Organization (WHO) group on schistosomiasis and helminth diseases transmitted through the soil (geo helminth diseases). Fio-Schisto is bound to the Vice-Presidency of Biological Research and Collections.
The invitation highlights that schistosomiasis and helminth diseases transmitted through the soil are a significant public health issue at a global level, which…
Article
The search for a coordinated solution to a common problem brought together representatives from Brazil, Argentina, Paraguay, Uruguay, and Bolivia this Tuesday (9/11) in the auditorium of the Immunobiological Technology Institute (Bio-Manguinhos). Organized by the Presidency Pro Tempore of Brazil in Mercosur, the Technical Seminar on Access to COVID-19 Vaccines: National Strategies and Possibilities of Expansion of the Regional Productive Capacity brought the sharing of experiences and challenges. The proposals that emerged in the debate - such as the suggestion of mapping the capacities and…
Article
Last Thursday (25 November) the Oswaldo Cruz Foundation, by means of its Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz), submitted to the Brazilian Health Regulatory Agency (Anvisa) a request of post-registration alteration of its COVID-19 vaccine (recombinant), asking to include the Institute as the manufacturing unit of the Active Pharmaceutical Ingredient (API). Check out this 360º view of the production area for the Brazilian API for vaccines, at Fiocruz.
Five batches of Brazilian API have been produced, and four of them are currently going through analytical…
Article